World Emerging Anti-Obesity Prescription Drug Markets

World Emerging Anti-Obesity Prescription Drug Markets

 

RELEASE DATE
10-Sep-2003
REGION
Global
Research Code: A643-01-00-00-00
SKU: HC00932-GL-MR_04760
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
HC00932-GL-MR_04760

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Emerging Anti-Obesity Prescription Drug Markets provides insight into the present challenges and growth opportunities in the global markets and changing trends that would impact the future potential. The study provides thoughts from the heads of prominent companies of the world with products in development.

Table of Contents

Overview

  • Introduction
  • Disclaimer
  • Certification
  • Research Scope and Methodology
  • Market Segmentation by Region
  • Market Segmentation by Product
  • Key Facts 1
  • Key Facts 2

Market Dynamics

  • Industry Challenges
  • CEO Quote
  • Market Trends

Demand Analysis

  • Prevalence of Obesity - World
  • Total Obese Population Forecasts - World
  • Obese Population - North America
  • Obese Population - Western Europe
  • Obese Population Forecasts - U.S. and W. Europe
  • Obese Population - Asia Pacific
  • Growth Drivers
  • CEO Quote

Market Forecasts

  • Existing Anti-Obesity Drugs Revenue Forecasts - U.S.
  • Total Revenue Forecasts by Geographical Regions - World
  • Global Market Size 1999 - 2009

Revenue Analysis

  • Market Revenue Analysis
  • Revenue Analysis by Geographical Regions

Evolving Markets

  • CEO Quote
  • Radar Screen
  • Customer Priorities and Market Scenario

Growth Strategies

  • Achieving Sustained Value Growth
  • Market Opportunity Matrix
  • Understanding Growth Opportunities 1
  • Understanding Growth Opportunities 2

Future Growth Areas

  • Growth Rates by Geographical Regions
  • Emerging Product's Landscape - I
  • Emerging Product's Landscape - II
  • Emerging Product's Landscape - III
  • Emerging Product's Landscape - IV
  • Emerging Product's Landscape - V

Econometrics

  • Macro Economic Analysis - I
  • Macro Economic Analysis - II
  • Macro Economic Analysis - III
  • Macro Economic Analysis - IV
  • Componenets of Macro Environment

What Future Holds?

  • Product Life Cycle Analysis
  • Already Known to 2010 and Beyond
  • Competition Framework
  • Target Markets for Anti-Obesity Treatment

Frost & Sullivan Awards

  • Introduction
  • Technology Innovation Award
  • Product Differentiation Award
  • Product Innovation Award

Frost & Sullivan

  • Healthcare Team
  • Our Capabilities
  • Key Advantages
  • Our Consulting Clients
  • Growth Consulting
  • Growth Consulting Process
  • Growth Consulting Deliverables
  • Growth Partnership Service (GPS)
  • Growth Partnership Services Platform
The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Emerging Anti-Obesity Prescription Drug Markets provides insight into the present challenges and growth opportunities in the global markets and changing trends that would impact the future potential. The study provides thoughts from the heads of prominent companies of the world with products in development.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A643-01-00-00-00
Is Prebook No